{"id": "hd7pcz", "title": "$LLY The COVID-19 Cure? A big opportunity", "selftext": "There\u2019s been a lot of talk of Gilead, Moderna, and other pharmaceuticals in creating the COVID-19 cure but Eli Lilly($LLY) has been left out of the mainstream media while big investors continue to secretly pile money into this company.\n\n\nThe big drugmaker has moved at breakneck speed with its partners to advance two COVID-19 antibody therapies into clinical studies. It's also evaluating blockbuster rheumatoid arthritis drug Olumiant and pipeline candidate LY3127804 in treating COVID-19.\n\n\nEngineers Gate Manager LP increased its position in Eli Lilly And Co (NYSE:LLY) by 521.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,007 shares of the company\u2019s stock after buying an additional 17,629 shares during the period. Engineers Gate Manager LP\u2019s holdings in Eli Lilly And Co were worth $2,914,000 at the end of the most recent quarter.\n\nSeveral other large investors have also recently bought and sold shares of LLY. BlackRock Inc. lifted its holdings in Eli Lilly And Co by 5.6% during the first quarter. BlackRock Inc. now owns 64,299,477 shares of the company\u2019s stock worth $8,919,623,000 after buying an additional 3,420,265 shares during the period.\n\nRecently, LLY announced successful results in their Phase 3 trials to reduce breast cancer. This news alone, should be huge revenue and they roll out their treatment to clinics. Bank of America and several other banks have a buy rating of $180.", "created_utc": 1592749278.0, "permalink": "/r/wallstreetbets/comments/hd7pcz/lly_the_covid19_cure_a_big_opportunity/", "is_self": true}